抗雄激素疗法:与抗凝固药物相互作用的管理
Arianne Duong1,2, Hanh Bui3, Dane Fritzsche2,4
1Department of Pharmacy, UW Medicine, Seattle, WA, USA.
概括
第二代抗雄激素可以与抗凝剂相互作用,影响前列腺癌治疗. 了解这些药物相互作用对于管理患者安全和确保有效治疗至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 药物新陈代谢 药物新陈代谢
背景情况:
- 第二代抗雄激素可以改善前列腺癌的结果.
- 这些药物的复杂的药理动力学可以导致药物相互作用 (DDI).
- 患有前列腺癌的患者通常需要慢性抗凝药治疗并发性疾病.
研究的目的:
- 对抗雄激素和常见抗凝剂之间的DDI进行审查.
- 分析药理动力学和药物代谢的临床影响.
- 为安全有效的患者护理提供指导.
主要方法:
- 对药物动力学数据,临床试验和处方信息的综合文献综述.
- 对抗雄激素和抗凝药物代谢的检查,包括CYP450和P-糖蛋白 (P-gp) 影响.
- 分析DDI对抗凝血剂有效性和安全性的影响.
主要成果:
- 恩扎胺和阿帕胺诱导CYP3A4,可能减少对华法林,阿皮克萨班和里瓦罗克萨班的暴露.
- 阿帕胺诱导P-gp,导致所有直接口服抗凝剂 (DOAC) 的DDI.
- 达洛胺和阿比拉特龙与华法林和DOACs的CYP450/P-gp相互作用很小.
结论:
- 抗雄激素和抗凝剂之间的DDI频繁,影响治疗的有效性和安全性.
- 跨专业的合作对于前列腺癌患者的药物选择至关重要.
- 药物动力学知识对于管理这些复杂的相互作用和确保患者护理至关重要.
更多相关视频
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Venous Thrombosis III: Interprofessional Care
257
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
257
Pharmacokinetics: Drug–Drug Interactions
316
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
316
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
185
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
185


